Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rumiko Shimazawa

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Design and synthesis of N-alkyl oxindolylidene acetic acids as a new class of potent Cdc25A inhibitorsRumiko Shimazawa, Masami Kuriyama, Ryuichi Shirai
Pharmacology Research & Perspectives|November 21, 2018
Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobialsRumiko Shimazawa, Yoshinobu Kano, Masayuki Ikeda
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Thalidomide and its analogues as cyclooxygenase inhibitorsTomomi Noguchi, Rumiko Shimazawa, Kazuo Nagasawa, et al.
The Journal of Organic Chemistry|August 7, 2008
Palladium-catalyzed 1,2-addition of potassium aryl- and alkenyltrifluoroborates to aldehydes using thioether-imidazolinium carbene ligandsMasami Kuriyama, Rumiko Shimazawa, Terumichi Enomoto, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Design and synthesis of dysidiolide analogs from vitamin D3: novel class of Cdc25A inhibitorsRumiko Shimazawa, Toshiyuki Suzuki, Kosuke Dodo, et al.
The Journal of Organic Chemistry|October 31, 2009
Efficient synthesis of 3-arylphthalides using palladium-catalyzed arylation of aldehydes with organoboronic acidsMasami Kuriyama, Natsuki Ishiyama, Rumiko Shimazawa, et al.
Chemical & Pharmaceutical Bulletin|April 2, 2004
Thalidomide as a nitric oxide synthase inhibitor and its structural developmentRumiko Shimazawa, Hiroko Sano, Aya Tanatani, et al.
Journal of Pharmacological Sciences|March 10, 2009
Repression of activated aryl hydrocarbon receptor-induced transcriptional activation by 5alpha-dihydrotestosterone in human prostate cancer LNCaP and human breast cancer T47D cellsNoriko Sanada, Yuka Gotoh, Rumiko Shimazawa, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Phenylhomophthalimide-type NOS inhibitors derived from thalidomideTomomi Noguchi, Hiroko Sano, Rumiko Shimazawa, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonistYuko Kato, Yusuke Nakano, Hiroko Sano, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Design and synthesis of N-alkyl oxindolylidene acetic acids as a new class of potent Cdc25A inhibitorsRumiko Shimazawa, Masami Kuriyama, Ryuichi Shirai
Pharmacology Research & Perspectives|November 21, 2018
Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobialsRumiko Shimazawa, Yoshinobu Kano, Masayuki Ikeda
Bioorganic & Medicinal Chemistry Letters|March 23, 2002
Thalidomide and its analogues as cyclooxygenase inhibitorsTomomi Noguchi, Rumiko Shimazawa, Kazuo Nagasawa, et al.
The Journal of Organic Chemistry|August 7, 2008
Palladium-catalyzed 1,2-addition of potassium aryl- and alkenyltrifluoroborates to aldehydes using thioether-imidazolinium carbene ligandsMasami Kuriyama, Rumiko Shimazawa, Terumichi Enomoto, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Design and synthesis of dysidiolide analogs from vitamin D3: novel class of Cdc25A inhibitorsRumiko Shimazawa, Toshiyuki Suzuki, Kosuke Dodo, et al.
The Journal of Organic Chemistry|October 31, 2009
Efficient synthesis of 3-arylphthalides using palladium-catalyzed arylation of aldehydes with organoboronic acidsMasami Kuriyama, Natsuki Ishiyama, Rumiko Shimazawa, et al.
Chemical & Pharmaceutical Bulletin|April 2, 2004
Thalidomide as a nitric oxide synthase inhibitor and its structural developmentRumiko Shimazawa, Hiroko Sano, Aya Tanatani, et al.
Journal of Pharmacological Sciences|March 10, 2009
Repression of activated aryl hydrocarbon receptor-induced transcriptional activation by 5alpha-dihydrotestosterone in human prostate cancer LNCaP and human breast cancer T47D cellsNoriko Sanada, Yuka Gotoh, Rumiko Shimazawa, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Phenylhomophthalimide-type NOS inhibitors derived from thalidomideTomomi Noguchi, Hiroko Sano, Rumiko Shimazawa, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonistYuko Kato, Yusuke Nakano, Hiroko Sano, et al.
Pageof 4